Latest Articles
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - Rutland Herald
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) Rutland Herald
Published: April 24, 2026, 10:11 p.m.
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha - Targeting ADC at AACR Annual Meeting 2026 - riauone.com
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha - Targeting ADC at AACR Annual Meeting 2026 riauone.com
Published: April 24, 2026, 4:01 a.m.
Case 3: Newly Diagnosed Advanced Uterine Papillary Serous Carcinoma - The ASCO Post
Case 3: Newly Diagnosed Advanced Uterine Papillary Serous Carcinoma The ASCO Post
Published: April 23, 2026, 9:09 p.m.
Why BioNTech (BNTX) Is Up 9.2% After Strong Phase 2 HER2 ADC Data In Endometrial Cancer - Yahoo Finance
Why BioNTech (BNTX) Is Up 9.2% After Strong Phase 2 HER2 ADC Data In Endometrial Cancer Yahoo Finance
Published: April 23, 2026, 8:06 p.m.
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - ACCESS Newswire
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) ACCESS Newswire
Published: April 23, 2026, 12:57 p.m.
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - News-Press NOW
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) News-Press NOW
Published: April 23, 2026, 12:56 p.m.
BioNTech (BNTX) Is Up 13.4% After Positive HER2 Endometrial Cancer Phase 2 Data Release - simplywall.st
BioNTech (BNTX) Is Up 13.4% After Positive HER2 Endometrial Cancer Phase 2 Data Release simplywall.st
Published: April 22, 2026, 11:30 a.m.
Endometriosis: Breaking the silence on a misunderstood disease - Jamaica Gleaner
Endometriosis: Breaking the silence on a misunderstood disease Jamaica Gleaner
Published: April 22, 2026, 5:05 a.m.
SURGE: Guardians Overcome Astros—Chase DeLauter and Kyle Manzardo SECURE Dramatic Victory - newscentermaine.com
SURGE: Guardians Overcome Astros—Chase DeLauter and Kyle Manzardo SECURE Dramatic Victory newscentermaine.com
Published: April 22, 2026, 4:11 a.m.
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 - The Manila Times
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 The Manila Times
Published: April 21, 2026, 9:40 p.m.
Link copied to clipboard!